Development of quinoline‑based 1,3,4-oxadiazole derivatives as <i>in vitro</i> anticancer agents targeting breast cancer cell lines

Srawanthi Kotoori, Karuna Sree Merugu, Aravind Kurnool, Baji Baba Shaik, Nagaraju Kerru

Open source

DOI: 10.1080/17568919.2026.2761367
Published: 2026-11-08
Container: Future Medicinal Chemistry
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/17568919.2026.2761367,
  title = {Development of quinoline‑based 1,3,4-oxadiazole derivatives as
                    <i>in vitro</i>
                    anticancer agents targeting breast cancer cell lines},
  author = {Srawanthi Kotoori and Karuna Sree Merugu and Aravind Kurnool and Baji Baba Shaik and Nagaraju Kerru},
  year = {2026},
  journal = {Future Medicinal Chemistry},
  doi = {10.1080/17568919.2026.2761367},
  url = {https://doi.org/10.1080/17568919.2026.2761367}
}

RIS

TY  - JOUR
TI  - Development of quinoline‑based 1,3,4-oxadiazole derivatives as
                    <i>in vitro</i>
                    anticancer agents targeting breast cancer cell lines
AU  - Srawanthi Kotoori
AU  - Karuna Sree Merugu
AU  - Aravind Kurnool
AU  - Baji Baba Shaik
AU  - Nagaraju Kerru
PY  - 2026
JO  - Future Medicinal Chemistry
DO  - 10.1080/17568919.2026.2761367
UR  - https://doi.org/10.1080/17568919.2026.2761367
ER  -

APA

Kotoori, S., Merugu, K. S., Kurnool, A., Shaik, B. B., & Kerru, N. (2026). Development of quinoline‑based 1,3,4-oxadiazole derivatives as <i>in vitro</i> anticancer agents targeting breast cancer cell lines. Future Medicinal Chemistry. https://doi.org/10.1080/17568919.2026.2761367

Source records

crossref · retrieved 2026-11-10T06:03:05.913Z